Literature DB >> 11257050

Combination effect of vancomycin and beta-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin.

N Aritaka1, H Hanaki, L Cui, K Hiramatsu.   

Abstract

We tested the combined activity of vancomycin and seven beta-lactam antibiotics against Staphylococcus aureus clinical strain Mu3, which displays heterogeneous resistance to vancomycin. When combined with vancomycin, four of the seven tested beta-lactams exhibited an additive effect at or near their MICs, while all showed an antagonistic effect at lower, sub-MIC levels. This study implicated the unpredictable nature of combination therapy of beta-lactams and vancomycin against S. aureus with reduced susceptibility to vancomycin.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11257050      PMCID： PMC90459          DOI： 10.1128/AAC.45.4.1292-1294.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  24 in total

1.  The effects of vancomycin and beta-lactam antibiotics on vancomycin-resistant Staphylococcus aureus.

Authors:  I Haraga; S Nomura; A Nagayama
Journal:  N Engl J Med       Date:  1999-11-18       Impact factor: 91.245

2.  Identification of the up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method.

Authors:  M Kuroda; K Kuwahara-Arai; K Hiramatsu
Journal:  Biochem Biophys Res Commun       Date:  2000-03-16       Impact factor: 3.575

3.  Evolution and resistance expression of MRSA. Evaluation of beta-lactam antibiotics against a set of isogenic strains with different types of phenotypic expression.

Authors:  K Asada; Y Inaba; E Tateda-Suzuki; K Kuwahara-Arai; T Ito; K Hiramatsu
Journal:  Acta Biochim Pol       Date:  1995       Impact factor: 2.149

4.  Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

Authors:  K Hiramatsu; H Hanaki; T Ino; K Yabuta; T Oguri; F C Tenover
Journal:  J Antimicrob Chemother       Date:  1997-07       Impact factor: 5.790

5.  Cell wall-affecting antibiotics induce expression of a novel gene, drp35, in Staphylococcus aureus.

Authors:  H Murakami; H Matsumaru; M Kanamori; H Hayashi; T Ohta
Journal:  Biochem Biophys Res Commun       Date:  1999-10-22       Impact factor: 3.575

6.  The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus.

Authors:  G Seibert; D Isert; N Klesel; M Limbert; A Markus; E Schrinner
Journal:  J Antimicrob Chemother       Date:  1992-04       Impact factor: 5.790

7.  In vitro activity of flomoxef and cefazolin in combination with vancomycin.

Authors:  C Simon; M Simon
Journal:  Infection       Date:  1991       Impact factor: 3.553

8.  [A novel method of detecting Staphylococcus aureus heterogeneously resistant to vancomycin (hetero-VRSA)].

Authors:  H Hanaki; Y Inaba; K Sasaki; K Hiramatsu
Journal:  Jpn J Antibiot       Date:  1998-08

9.  Effect of combination of oxacillin and non-beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus.

Authors:  H Komatsuzawa; J Suzuki; M Sugai; Y Miyake; H Suginaka
Journal:  J Antimicrob Chemother       Date:  1994-06       Impact factor: 5.790

10.  Penicillin-binding proteins in bacteria.

Authors:  N H Georgopapadakou; F Y Liu
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191
View more
  14 in total

1.  Transcriptomic and functional analysis of an autolysis-deficient, teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.

Authors:  Adriana Renzoni; Christine Barras; Patrice François; Yvan Charbonnier; Elzbieta Huggler; Christian Garzoni; William L Kelley; Paul Majcherczyk; Jacques Schrenzel; Daniel P Lew; Pierre Vaudaux
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  High-level oxacillin and gentamycin resistance with reduced susceptibility to vancomycin in Staphylococcus aureus-carrying mecA and femA gene complex.

Authors:  S Raju; R Kelmani Chandrakanth; S A Patil
Journal:  Curr Microbiol       Date:  2007-04-24       Impact factor: 2.188

3.  In vivo synergism of ceftobiprole and vancomycin against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus.

Authors:  J M Entenza; T R Veloso; J Vouillamoz; M Giddey; P Majcherczyk; P Moreillon
Journal:  Antimicrob Agents Chemother       Date:  2011-07-05       Impact factor: 5.191

4.  Efficacy of fosfomycin and its combination with linezolid, vancomycin and imipenem in an experimental peritonitis model caused by a Staphylococcus aureus strain with reduced susceptibility to vancomycin.

Authors:  M E Pachón-Ibáñez; S Ribes; M A Domínguez; R Fernández; F Tubau; J Ariza; F Gudiol; C Cabellos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-16       Impact factor: 3.267

5.  Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea.

Authors:  Mi-Na Kim; Sang Hyun Hwang; Yeon-Jung Pyo; Hyang-Mi Mun; Chik Hyun Pai
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

6.  Novel combinations of vancomycin plus ceftaroline or oxacillin against methicillin-resistant vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA.

Authors:  B J Werth; C Vidaillac; K P Murray; K L Newton; G Sakoulas; P Nonejuie; J Pogliano; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2013-02-19       Impact factor: 5.191

7.  Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus.

Authors:  Longzhu Cui; Xiaoxue Ma; Katsuhiro Sato; Keiko Okuma; Fred C Tenover; Elsa M Mamizuka; Curtis G Gemmell; Mi-Na Kim; Marie-Cecile Ploy; N El-Solh; Vivian Ferraz; Keiichi Hiramatsu
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

8.  Nosocomial spread of a Staphylococcus capitis strain with heteroresistance to vancomycin in a neonatal intensive care unit.

Authors:  Wil C Van Der Zwet; Yvette J Debets-Ossenkopp; Erik Reinders; Maria Kapi; Paul H M Savelkoul; Ruurd M Van Elburg; Keiichi Hiramatsu; Christina M J E Vandenbroucke-Grauls
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

9.  Synergy of β-Lactams with Vancomycin against Methicillin-Resistant Staphylococcus aureus: Correlation of Disk Diffusion and Checkerboard Methods.

Authors:  Cheng Len Sy; Tsi-Shu Huang; Chii Shiang Chen; Yao-Shen Chen; Hung-Chin Tsai; Shue-Renn Wann; Kuan-Sheng Wu; Jui-Kuang Chen; Susan Shin-Jung Lee; Yung-Ching Liu
Journal:  J Clin Microbiol       Date:  2015-12-16       Impact factor: 5.948

10.  Interactions between glycopeptides and beta-lactams against isogenic pairs of teicoplanin-susceptible and -resistant strains of Staphylococcus haemolyticus.

Authors:  Carla Vignaroli; Francesca Biavasco; Pietro E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.